ST7L (Suppression of Tumorigenicity 7 Like) has been implicated in various cellular processes, particularly in cancer development.
Multiple indicators should be collected to provide a more complete picture of antibody responses in community settings. Based on research from King's College London, combining self-reported symptoms, participant suspicion of infection, and antibody testing results offers more reliable data than any single measure alone. Their study demonstrated that relying on a single indicator (such as external test results or self-reported symptoms) may lead to under or overestimation of prevalence . The most complete approach involves:
Collection of detailed symptom information using validated symptom algorithms
Documentation of participant suspicion of infection
Results of any external testing participants may have received
Laboratory or point-of-care antibody testing
Follow-up testing to account for potential antibody waning
This multi-indicator approach allows researchers to develop algorithms that maximize case history identification rather than relying on single measures that may provide a false sense of certainty .
Home antibody testing using lateral flow devices can be a practical approach for community-based research studies, but comes with important considerations. Research from King's College London found that participants could successfully perform these tests when provided with illustrated instructions and access to responsive support . Their study showed:
High proportion of participants (90%+) returned valid test results
Participants could effectively photograph and submit results for research team verification
Minimal issues when proper instructions and support were provided
Accounting for temporal dynamics of antibody responses is critical in research study design. Evidence from COVID-19 studies indicates antibody levels may decline significantly over time, particularly after mild infections . Key considerations include:
Antibodies may decline over 3+ months post-infection, especially on lateral flow devices, affecting sensitivity
Mild infections produce more inconsistently detected antibody responses than severe cases
Some individuals may not produce detectable anti-spike antibodies despite infection
For optimal study design, researchers should:
Document the timing of suspected infection and any symptoms
Include repeated antibody testing at strategic intervals
Consider supplementing antibody testing with T-cell response testing for tracking long-term immunity
Implement mathematical modeling to account for potential antibody waning when estimating prevalence
The King's College study noted that testing occurring at least three months after symptom onset may miss cases due to antibody waning, suggesting that single time-point antibody testing has limitations for retrospective case identification .
When faced with discordant indicators (symptoms, participant suspicion, and antibody test results), researchers should implement structured analysis approaches. The King's College study provides valuable insights on this challenge :
Analyze each indicator's sensitivity and specificity against available reference standards
Create intersectional groups based on combinations of indicators
Report proportions testing positive within each intersectional group
Their analysis revealed that participant suspicion significantly modified the probability of testing positive within symptom categories. For example, 49% of participants with positive symptom algorithm scores and "definite" suspicion tested antibody positive, compared to only 13% of those with positive symptom scores but "unsure" suspicion . This demonstrates that analyzing the intersections of multiple indicators provides more nuanced understanding than any single indicator alone.
Based on research evidence, optimal antibody testing approaches for community-based cohort studies should balance practicality, acceptability, and accuracy . Key recommendations include:
Select testing platforms with high specificity (>98%) to minimize false positives, particularly important in large population studies with expected low prevalence
Consider the trade-off between laboratory-based testing (higher accuracy but lower participation) versus home-based testing (potentially lower accuracy but higher participation)
Implement quality control measures such as photographic verification of test results
Provide clear illustrated instructions and responsive support for home testing
Train research staff to interpret results consistently
The King's College London study demonstrated that home-based lateral flow cassette testing can be implemented successfully in community cohorts when accompanied by appropriate support and verification systems, with minimal invalid results .
Developing integrated classification algorithms represents an important methodological approach when definitive contemporaneous testing is unavailable. Based on the King's College London experience, researchers should consider :
Implementing validated symptom algorithms (such as the COVID Symptom Study algorithm)
Weighting participant suspicion as a modifier of symptom-based classification
Incorporating antibody testing as an objective measure while acknowledging potential false negatives due to waning
Analyzing the sensitivity and specificity of different algorithm combinations against available reference standards
Their research demonstrated that combining these indicators provided improved classification compared to single measures. For example, having core COVID-19 symptoms alone yielded a 14% probability of positive antibody testing, while having core symptoms plus definite suspicion yielded a 38% probability of positive antibody testing .
Researchers should be aware of several critical limitations when using antibody testing for retrospective case identification :
Sensitivity limitations: Antibody levels may wane over time, especially after mild infection
Biological variation: A small percentage of people do not produce detectable antibodies despite infection
Timing challenges: The optimal window for antibody detection varies based on test platform and severity of infection
Test technology considerations: Lateral flow devices typically have lower sensitivity than laboratory-based assays
The King's College London study found evidence suggesting antibody test sensitivity declines when testing occurs months after infection. Among participants who reported previous antibody testing elsewhere, only 15% were positive on their study antibody test, compared with 24% who reported positive results on earlier external antibody tests .
Based on current research, several promising approaches could address existing limitations :
Integration of T-cell response testing alongside antibody testing to better track long-term immunity
Development of more sensitive point-of-care antibody tests optimized for detecting waned responses
Implementation of statistical approaches that account for time-dependent sensitivity decline
Creation of standardized algorithms combining multiple indicators with weighted importance
The King's College London researchers suggest that augmenting antibody testing with T-cell response testing may be possible in the future to better track long-term immunity . They also emphasize the importance of developing algorithms that maximize case history identification rather than relying on single measures which may provide a false sense of certainty.